Please provide your email address to receive an email when new articles are posted on . This activity is supported by educational grants from AbbVie Inc.; Genentech, a member of the Roche Group; ...
A recent study published in Science Advances reports a microbiome-targeted therapy to improve inflammatory bowel disease (IBD): microRNA (miRNA)-encapsulated biomimetic lipid nanoparticles (LNPs) that ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果